Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 199 of 1,261

  1. US 11633416

    Oral formulations of CD73 compounds

    Arcus Biosciences, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  2. US 11634463

    Methods and compositions for treating hemophilia

    Sangamo Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  3. US 11633461

    Enzymes and methods for cleaving n-glycans from glycoproteins

    The Regents of the University of California · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  4. US 11634418

    Amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  5. US 11633361

    Soft chew pharmaceutical formulations

    First Time US Generics LLC · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  6. US 11629167

    Betulastatin compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  7. US 11629146

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity

    PRAXIS PRECISION MEDICINES, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  8. US 11629174

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinomycete bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  9. US 11629122

    Linkers for antibody drug conjugates

    The Board of Regents of the University of Texas System · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  10. US 11629060

    Purification of clinoptilolite

    Revelation Health LLC · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  11. US 11629195

    Anti-IL2 receptor gamma antigen-binding proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  12. US 11628205

    Conjugates of a factor VIII moiety having an oxime-containing linkage

    Nektar Therapeutics · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  13. US 11628173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  14. US 11629334

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  15. US 11628177

    Compositions and methods for deep dermal drug delivery

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  16. US 11629348

    Linkage modified oligomeric compounds and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  17. US 11629372

    Random heteropolymers preserve protein function in foreign environments

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  18. US 11628010

    Selective fat removal using photothermal heating

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  19. US 11628215

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  20. US 11629349

    RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  21. US 11631483

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  22. US 11628146

    Estrogen receptor ligand treatment for neurodegenerative diseases

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  23. US 11629159

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  24. US 11629145

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.